Previous Article | Next Article ![]()
Journal of Clinical Microbiology, January 1999, p. 152-156, Vol. 37, No. 1
Department of Medical Microbiology,
University of Zürich, CH-8028 Zürich, Switzerland
Received 24 August 1998/Returned for modification 28 September
1998/Accepted 17 October 1998
The current genetic strategies used to identify Tropheryma
whippelii, the putative agent of Whipple's disease, are based on PCR-mediated amplification of a part of its 16S rRNA gene (16S rDNA).
Because there is very little intraspecies variation in these molecules,
they are not suitable as targets for epidemiologic investigations.
However, the intergenic spacer region between the 16S and 23S rDNAs is
usually much more variable and has repeatedly been used for
epidemiologic purposes. We have therefore amplified the spacer region
of T. whippelii directly from clinical specimens from nine
independent Swiss patients with Whipple's disease by PCR with primers
complementary to the 3' and 5' ends of the 16S and 23S rDNAs,
respectively. The amplicons were directly sequenced and the sequences
were compared to the T. whippelii reference sequence in
GenBank/EMBL (accession no. X99636). Complete sequence homogeneity was
found between the samples from our nine patients; the spacer sequence
was also identical to the reference sequence. However, the sequences
corresponding to the 3' and 5' ends of the 16S and the 23S rDNAs of
T. whippelii, respectively, differed from the respective
sequences in GenBank/EMBL. The same sequence found in our patients was
then found in a sample from the German patient from which the published
sequence had been derived. We conclude that the 16S-23S rDNA spacer
region seems to be very conserved in T. whippelii and that
the respective reference entry in public databases should be revised.
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Homogeneity of 16S-23S Ribosomal Intergenic Spacer
Regions of Tropheryma whippelii in Swiss Patients with
Whipple's Disease
*
Corresponding author. Mailing address: Department of
Medical Microbiology, University of Zürich, Gloriastrasse 30, 8028 Zürich, Switzerland. Phone: 41-1-634 27 00. Fax:
41-1-634 49 06. E-mail: altwegg{at}immv.unizh.ch.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»